| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8235528 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 6 Pages |
Abstract
Hypofractionated proton beam therapy is safe and well-tolerated by patients with HCC located greater than 2 cm away from the porta hepatis or gastrointestinal tract and may be effective alternative to other modalities.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Nobuyoshi M.D., Shinji M.D., Hidetsugu M.D., Kuniaki M.D., Masashi M.D., Masato M.D., Junichi M.D., Eriko M.D., Koji M.D., Koichi M.D.,